Consider an illustrative electronics launch managed from Singapore and assembled in Vietnam. At the weekly call, the contract manufacturer reports that assembly is progressing to plan. Two days later, the shipment moves. A test failure has held finished units, and a missing component has prevented the remaining builds from starting. Neither issue appeared in the earlier update.
The problem was not necessarily dishonest reporting. The customer and manufacturer were using different meanings of “on track.” One meant work was underway. The other meant the committed quantity could still be shipped on the agreed date.
Contract manufacturing visibility is the ability to verify a delivery commitment against material readiness, actual production events, quality disposition and the remaining time to recover. Here is how procurement can help build that view without trying to manage the supplier’s factory.
Start with the orders where a late surprise would hurt
A factory-wide dashboard may be difficult to obtain and harder to use. Begin with the products and orders for which a missed handover would interrupt a customer launch, shut down a line or create a costly recovery decision.
The procurement owner and internal operations lead should agree which purchase orders, product revisions and shipment milestones require enhanced tracking. The manufacturer’s planner then links each order to the relevant production batch or work order. Without that link, a report of “units produced” may include output intended for other customers or a different revision.
Record the baseline before monitoring begins: accepted order quantity, approved specification revision, planned production gates, agreed delivery point and the person authorized to accept a change. This creates a reference for later exceptions. A revised promise should remain visible alongside the original commitment, rather than quietly replacing it.
Replace percentage complete with a small event record
A single percentage can hide unfinished testing, rework and material shortages. Ask the manufacturer to report a handful of events tied to the actual order, using quantities and timestamps rather than subjective status labels.
| Control point | Minimum evidence to share | Decision it supports |
|---|---|---|
| Material ready | Critical parts allocated to the order; approved revision and shortage exceptions | Can the planned build start? |
| Production started and progressed | Work-order reference, completed operation, good and held quantities, timestamp | Is output advancing at the required rate? |
| Quality disposition | Inspection or test status, rejected or quarantined quantity, release authority | Which units are actually eligible to ship? |
| Dispatch ready | Released quantity, packing status, confirmed pickup or handover | Can the customer rely on the ship date? |
These are proposed management fields, not a universal manufacturing standard. A highly automated site may supply them through system integration; another may use a controlled daily extract. The essential point is common definitions and traceable records.
GS1’s EPCIS standard uses event records to describe what happened, when, where and in what business context. NIST’s September 2026 manufacturing traceability framework similarly addresses linking verifiable information across fragmented systems. Neither requires procurement to demand unrestricted access to the manufacturer’s internal systems.
Test whether the remaining schedule is still executable
At an agreed review cadence, the manufacturer’s planner reconciles the event record with the open commitment. Internal operations should challenge any mismatch between the quantities required, the materials allocated, the stages completed, the units still held by quality and the time available before dispatch.
Take a build that appears on schedule because assembly has started. If a critical component is allocated only to the first batch, the later builds are still exposed. If final testing is the constraint, extra assembly shifts may increase work-in-process without improving the releasable quantity.
The useful question is: What must be true at the next production gate for this delivery date to remain credible? Ask for the specific evidence and recovery assumptions behind that answer. Where the answer cannot be substantiated, mark the commitment at risk rather than declaring a delay as certain.
Give every exception a decision route
Data becomes operationally useful when a deviation has a named owner and a path to resolution. Agree triggers before the next shortage or quality hold occurs: a missed critical gate, unavailable allocated material, an unauthorized revision, a significant yield issue or a proposed change to the committed date.
The manufacturer’s site lead owns immediate diagnosis and recovery options. The buyer’s operations or program lead assesses schedule consequences. Quality decides technical containment, acceptance and release within its authority. Procurement manages commercial escalation, contractual remedies and any proposed change to allocation or delivery terms.
For critical issues, require notification as soon as the problem is identified, without waiting for the next routine report. The contract and quality arrangements should define the applicable notification windows; one universal number would be misleading across products and industries.
An exception record should show the affected order and revision, the verified cause or current hypothesis, quantity exposed, immediate containment, recovery choices, decision owner and next review point. Keep unconfirmed causes clearly marked as such.
Close the exception only after the accountable owner reviews the evidence: material received and allocated, a successfully demonstrated process recovery, quality-approved release or an expressly approved revised delivery commitment. A supplier email saying “resolved” is not closure. Nor can procurement authorize shipment of units still under a quality hold.
Agree on access rights before requesting more transparency
Visibility depends on what the parties have agreed to exchange. During onboarding or contract renewal, specify reporting definitions, source records, audit or verification rights, exception-notification duties, permitted subcontracting and escalation contacts. Include data security, confidentiality and retention arrangements appropriate to the products and jurisdictions involved.
The buyer does not automatically need the manufacturer’s customer list, complete production schedule or proprietary process settings. It needs defensible evidence for its own orders and a way to verify disputed claims. Where direct system access is unsuitable, use controlled extracts, agreed evidence samples or independent verification.
Sector rules still matter. For US-regulated drug manufacturing, the FDA’s November 2016 quality-agreement guidance describes how parties should document their respective CGMP manufacturing activities. That guidance is sector-specific; an electronics or apparel program should not treat it as a universal legal template.
Pilot the mechanism on one live program
Choose a product with meaningful delivery exposure and one manufacturer willing to test the approach. Map its order-to-work-order links, agree the event definitions and run the reconciliation within the existing planning meeting. Use a simple exception log before considering a new software platform.
Review whether missing signals were found earlier, whether recovery decisions used verified evidence and whether problems remained open until effectiveness was checked. If the process produces more reports but no earlier decisions, simplify the data set and revisit who has authority to act.
The purpose of contract manufacturing visibility is not to watch every production step. It is to know whether the next delivery promise is still achievable, what threatens it, and who can act while there is still time.